PMC:7696151 / 68299-68535 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1984","span":{"begin":43,"end":61},"obj":"Chemical"},{"id":"1985","span":{"begin":74,"end":87},"obj":"Chemical"}],"attributes":[{"id":"A1984","pred":"tao:has_database_id","subj":"1984","obj":"MESH:D008775"},{"id":"A1985","pred":"tao:has_database_id","subj":"1985","obj":"MESH:D014221"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"scular injection (i.m.) doses of 120 mg of methylprednisolone or 80 mg of triamcinolone) with respect to single therapy after three months, without significant differences in side effects [125]. Proofs of the better antirheumatic potent"}